OpGen Inc (OPGN)

[cadtime415]

Once again I have to completely agree with your outlook.

The earnings call was spot on, and management achieved exactly what was promised. All investors should be quite pleased, and completely confident in the OPGN leadership team.

As for the future outlook, the longer the PPS stays in this range, the more likely OPGN becomes a true take over target, and sooner rather than later.

(Personally, the current MC of approximately 15M is way too low, given all that we know about OPGN's future goals and events. Too me, the .50 - .60 PPS range would be more realistic of what is to occur in the not so distant future here. 2018.)

Each and every positive development, provides more and more, reason & resolve, that Merck will continue their positioning.

(The .40's will clearly show their hand in this regard, and fuel a solid climb to much higher levels. Of course, while providing working capital to achieve the main goal of FDA approval.)

I feel great holding my position, and adding more to it at this time. Even though we may not see lots of action in regards to the PPS action at this time, we can surely expect lots of action in regards to solid events and continued positive progress as we finish out 2017 and begin 2018.

Cad